Aging and inflammation limit the induction of SARS-CoV-2-specific CD8+ T cell responses in severe COVID-19

衰老和炎症会限制重症 COVID-19 患者体内 SARS-CoV-2 特异性 CD8+ T 细胞反应的诱导。

阅读:11
作者:Gaëlle Autaa ,Laura Papagno ,Takuto Nogimori ,Andrea Boizard-Moracchini ,Daniil Korenkov ,Maeva Roy ,Koichiro Suzuki ,Yuji Masuta ,Eoghann White ,Sian Llewellyn-Lacey ,Yasuo Yoshioka ,Francesco Nicoli ,David A Price ,Julie Dechanet-Merville ,Takuya Yamamoto ,Isabelle Pellegrin ,Victor Appay

Abstract

CD8+ T cells are critical for immune protection against severe COVID-19 during acute infection with SARS-CoV-2. However, the induction of antiviral CD8+ T cell responses varies substantially among infected people, and a better understanding of the mechanisms that underlie such immune heterogeneity is required for pandemic preparedness and risk stratification. In this study, we analyzed SARS-CoV-2-specific CD4+ and CD8+ T cell responses in relation to age, clinical status, and inflammation among patients infected primarily during the initial wave of the pandemic in France or Japan. We found that age-related contraction of the naive lymphocyte pool and systemic inflammation were associated with suboptimal SARS-CoV-2-specific CD4+ and, even more evidently, CD8+ T cell immunity in patients with acute COVID-19. No such differences were observed for humoral immune responses targeting the spike protein of SARS-CoV-2. We also found that the proinflammatory cytokine IL-18, concentrations of which were significantly elevated among patients with severe disease, suppressed the de novo induction and memory recall of antigen-specific CD8+ T cells, including those directed against SARS-CoV-2. These results potentially explain the vulnerability of older adults to infections that elicit a profound inflammatory response, exemplified by acute COVID-19.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。